These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 32252470)

  • 1. Diagnostic and Therapeutic Potential of TSPO Studies Regarding Neurodegenerative Diseases, Psychiatric Disorders, Alcohol Use Disorders, Traumatic Brain Injury, and Stroke: An Update.
    Dimitrova-Shumkovska J; Krstanoski L; Veenman L
    Cells; 2020 Apr; 9(4):. PubMed ID: 32252470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 18-kDa Translocator Protein as a CNS Drug Target: Finding Our Way Through the Neuroinflammation Fog.
    Filiou MD; Banati RB; Graeber MB
    CNS Neurol Disord Drug Targets; 2017; 16(9):990-999. PubMed ID: 28982340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSPO in diverse CNS pathologies and psychiatric disease: A critical review and a way forward.
    Guilarte TR
    Pharmacol Ther; 2019 Feb; 194():44-58. PubMed ID: 30189290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
    Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
    J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO.
    Narayanaswami V; Dahl K; Bernard-Gauthier V; Josephson L; Cumming P; Vasdev N
    Mol Imaging; 2018; 17():1536012118792317. PubMed ID: 30203712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases.
    Dupont AC; Largeau B; Santiago Ribeiro MJ; Guilloteau D; Tronel C; Arlicot N
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387722
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Chaney A; Cropper HC; Johnson EM; Lechtenberg KJ; Peterson TC; Stevens MY; Buckwalter MS; James ML
    J Nucl Med; 2019 Jan; 60(1):122-128. PubMed ID: 29976695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders.
    Werry EL; Bright FM; Piguet O; Ittner LM; Halliday GM; Hodges JR; Kiernan MC; Loy CT; Kril JJ; Kassiou M
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis.
    Nutma E; Stephenson JA; Gorter RP; de Bruin J; Boucherie DM; Donat CK; Breur M; van der Valk P; Matthews PM; Owen DR; Amor S
    Brain; 2019 Nov; 142(11):3440-3455. PubMed ID: 31578541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological modulation of TSPO in microglia/macrophages and neurons in a chronic neurodegenerative model of prion disease.
    Vicente-Rodríguez M; Mancuso R; Peris-Yague A; Simmons C; ; Gómez-Nicola D; Perry VH; Turkheimer F; Lovestone S; Parker CA; Cash D
    J Neuroinflammation; 2023 Apr; 20(1):92. PubMed ID: 37032328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection.
    Da Pozzo E; Giacomelli C; Barresi E; Costa B; Taliani S; Passetti Fda S; Martini C
    Biochem Soc Trans; 2015 Aug; 43(4):559-65. PubMed ID: 26551693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging neuroinflammation with TSPO: A new perspective on the cellular sources and subcellular localization.
    Guilarte TR; Rodichkin AN; McGlothan JL; Acanda De La Rocha AM; Azzam DJ
    Pharmacol Ther; 2022 Jun; 234():108048. PubMed ID: 34848203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease.
    Best L; Ghadery C; Pavese N; Tai YF; Strafella AP
    Curr Neurol Neurosci Rep; 2019 Apr; 19(5):24. PubMed ID: 30941587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracing the History of the Human Translocator Protein to Recent Neurodegenerative and Psychiatric Imaging.
    Downer OM; Marcus REG; Zürcher NR; Hooker JM
    ACS Chem Neurosci; 2020 Aug; 11(15):2192-2200. PubMed ID: 32662626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A translocator protein 18 kDa agonist protects against cerebral ischemia/reperfusion injury.
    Li HD; Li M; Shi E; Jin WN; Wood K; Gonzales R; Liu Q
    J Neuroinflammation; 2017 Jul; 14(1):151. PubMed ID: 28754131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic actions of translocator protein (18 kDa) ligands in experimental models of psychiatric disorders and neurodegenerative diseases.
    Arbo BD; Benetti F; Garcia-Segura LM; Ribeiro MF
    J Steroid Biochem Mol Biol; 2015 Nov; 154():68-74. PubMed ID: 26200949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TSPO Ligands 2-Cl-MGV-1, MGV-1, and PK11195 Differentially Suppress the Inflammatory Response of BV-2 Microglial Cell to LPS.
    Azrad M; Zeineh N; Weizman A; Veenman L; Gavish M
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of alcoholism and cholesterol on TSPO binding in brain: PET [
    Kim SW; Wiers CE; Tyler R; Shokri-Kojori E; Jang YJ; Zehra A; Freeman C; Ramirez V; Lindgren E; Miller G; Cabrera EA; Stodden T; Guo M; Demiral ŞB; Diazgranados N; Park L; Liow JS; Pike V; Morse C; Vendruscolo LF; Innis RB; Koob GF; Tomasi D; Wang GJ; Volkow ND
    Neuropsychopharmacology; 2018 Aug; 43(9):1832-1839. PubMed ID: 29777199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocator Protein 18-kDa: A Promising Target to Treat Neuroinflammation- related Degenerative Diseases.
    Tremolanti C; Germelli L; Barresi E; Da Pozzo E; Simorini F; Castellano S; Taliani S; Da Settimo F; Martini C; Costa B
    Curr Med Chem; 2022 Aug; 29(28):4831-4861. PubMed ID: 35430971
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.